Luteal Phase Commencing of Growth Hormone
NCT00561769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61
Last updated 2007-11-21
Summary
Commencing of growth hormone in luteal phase when follicular cohort for the next cycle is being gathered may increase mature oocytes in poor responder
Conditions
Interventions
- DRUG
-
Norditropin pen
12 IU per day
Sponsors & Collaborators
-
Ren-Tıp ART Center, Bursa, Turkey
collaborator UNKNOWN -
Gulhane School of Medicine
lead OTHER
Principal Investigators
-
Tansu Kucuk, Assoc Prof · GATA Ankara
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Completion
- 2007-11-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
In Vitro Fertilization Outcomes of Two Treatment Protocols in Women With Polycystic Ovary Syndrome
NCT01354275 ·Status: TERMINATED ·Phase: NA
-
The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes
NCT02114645 ·Status: UNKNOWN ·Phase: NA
-
Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles
NCT00669786 ·Status: COMPLETED ·Phase: PHASE3
-
Three Small Doses of HCG Versus Booster Dose of HCG on Ovum Pickup Day
NCT02397551 ·Status: COMPLETED ·Phase: PHASE4
-
Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients
NCT01298960 ·Status: TERMINATED ·Phase: PHASE2
-
Ovarian Stimulation With FSH Alone Versus FSH Plus GnRH Antagonist in an Oocyte Donor/Recipient Programme
NCT05759871 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Comparison of Granulosa Cell Apoptosis Rates With or Without Luteinizing Hormone Administration in Poor Responders.
NCT03527823 ·Status: COMPLETED
-
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
NCT01037699 ·Status: COMPLETED ·Phase: PHASE3
-
Gonadotrophin Dosage Using a Threshold Nomogram for Ovulation Induction in WHO Group II Anovulatory Infertility
NCT01250821 ·Status: COMPLETED ·Phase: PHASE4
-
Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS
NCT02200952 ·Status: COMPLETED
-
GnRH Agonist for Luteal Phase Support.
NCT05484193 ·Status: UNKNOWN ·Phase: NA
-
Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve
NCT05567731 ·Status: COMPLETED ·Phase: NA
-
Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)
NCT00954811 ·Status: UNKNOWN ·Phase: PHASE4
-
Short Versus Long Protocol for IVF and IVF+ICSI
NCT00756028 ·Status: COMPLETED ·Phase: PHASE4
-
Prolonged Protocol of Early Follicular or Mid Luteal Phase
NCT04522479 ·Status: UNKNOWN ·Phase: NA
-
rFSH vs rFSH+rLH in Dydrogesterone-Based Progestin Protocol: A Prospective Study
NCT07348757 ·Status: RECRUITING
-
An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients
NCT05569577 ·Status: RECRUITING ·Phase: NA
-
The Luteal Phase After GnRHa Trigger - a Proof of Concept Study
NCT01504139 ·Status: COMPLETED ·Phase: PHASE4
-
Microflare Protocol in Poor Responders
NCT02185326 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.
NCT00334425 ·Status: UNKNOWN ·Phase: PHASE4
-
Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a
NCT05143723 ·Status: UNKNOWN ·Phase: PHASE2
-
GnRh Antagonist Protocol With Delayed Start Stimulation in Patients With Poor Ovarian Response
NCT03134690 ·Status: COMPLETED ·Phase: NA
-
GnRH Agonist as Luteal Support in FET Cycles
NCT02620124 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program
NCT03237117 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
NCT02312076 ·Status: RECRUITING ·Phase: PHASE4